ArticleBMC cancer2024

Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.

Graham McIlroy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.